Who founded Instapath Inc.?

Instapath Inc. was founded by Mei Wang, Quincy Brown, David Tulman in 2017.

Who are Instapath Inc.'s investors?

Instapath Inc.'s investors include Draper Associates, Y Combinator.

How much funding has Instapath Inc. raised?

Instapath Inc. has disclosed $1.8M raised across 1 round.

Where is Instapath Inc. headquartered?

Instapath Inc. is headquartered in Houston, US.

Instapath Inc.

YC W19

Houston, US · Founded 2017 · Delaware corporation · 6 employees · 2 known investors

Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.

Biotech Deep Tech Healthtech Medical DevicesUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W19)

Instapath Inc. was founded in 2017 by Mei Wang, Quincy Brown, and David Tulman.

Mei Wang inCofounderMei Wang is co-founder and CEO of Instapath Inc.

Quincy BrowninCo-founder · CRO

David TulmaninFounder

Investors · 2

Draper AssociatesSan Mateo · $500K – $5M

Y CombinatorSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 1 round · 2019

▶$1.8MraisedSep 2019 · 20 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

David TulmanExecutive Officer, Director
David TulmanExecutive Officer, Director
David TulmanExecutive Officer, Director
David TulmanExecutive Officer, Director

Offering amount: $1.8M
Amount sold: $1.8M
First sale: Sep 2019
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Clarapath15 shared keywordsClarapath develops SectionStar, an automated tissue sectioning system for histology laboratories that aims to improve slide quality, reduce turnaround time and lower costs. The company builds healthcare robotics for laboratory medicine and pathology workflows.

mPATH Health8 shared keywordsmPATH is a digital patient navigation platform that automates cancer screening outreach, eligibility verification, decision support, and completion tracking for health systems, working alongside existing EHRs without integration. It targets healthcare providers seeking to improve screening completion rates, HEDIS/Stars quality scores, and value-based contract performance.

Companies competing with Instapath Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Science Foundation	Phase II	2021	$1M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Instapath Inc. do?: Instapath develops rapid digital pathology microscopy platforms that enable cancer diagnosis from tissue samples in minutes rather than days. The technology serves pathology labs and healthcare providers to accelerate cancer diagnosis and reduce repeat biopsy procedures.
Who founded Instapath Inc.?: Instapath Inc. was founded by Mei Wang, Quincy Brown, David Tulman in 2017.
Who are Instapath Inc.'s investors?: Instapath Inc.'s investors include Draper Associates, Y Combinator.
How much funding has Instapath Inc. raised?: Instapath Inc. has disclosed $1.8M raised across 1 round.
Where is Instapath Inc. headquartered?: Instapath Inc. is headquartered in Houston, US.